Largest review to date of ivermectin use in cancer patients finds no safety concerns, promising anecdotal reports, and strong preclinical evidence of tumor suppression.
The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research
This systematic review aimed to evaluate the potential for repurposing ivermectin as an anticancer agent, through a dual focus on:
- The clinical safety of ivermectin in cancer patients, based on case reports and series involving its use for parasitic infections
- The preclinical antitumor activity of ivermectin, drawn from laboratory and animal studies
A total of 2,273 publications were identified, of which 26 studies met inclusion criteria. These studies involved 36 cancer patients who had received oral ivermectin, primarily for parasitic infections.
While none of the patient cases were designed to evaluate antitumor effects, the review also summarizes a growing body of preclinical evidence supporting ivermectin’s potential anticancer mechanisms.
So… Is it any surprise that they have been going after everyone that has been trying to promote Ivermectin as a good thing since 2020? Drump was up and front in trying to promote it with the intent of having everyone poo-poo it… because Drump said it.
I heard a few years back that cancer can easily be a byproduct of parasitic infection, which Ivermectin is made to treat. Among many things, if Ivermectin starts being used as an effective means of treating just about everything, then the entire pharma industry would be in serious trouble. Their entire industrial model is about treating the symptoms, never the problem.